<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "JATS-journalpublishing1.dtd">
<article article-type="editorial" dtd-version="1.0" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">KJP</journal-id>
<journal-title-group>
<journal-title>Korean Journal of Pediatrics</journal-title><abbrev-journal-title>Korean J Pediatr</abbrev-journal-title></journal-title-group>
<issn pub-type="ppub">1738-1061</issn>
<issn pub-type="epub">2092-7258</issn>
<publisher>
<publisher-name>Korean Pediatric Society</publisher-name></publisher></journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3345/kjp.2019.00129</article-id>
<article-id pub-id-type="publisher-id">kjp-2019-00129</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Editorial</subject>
<subj-group subj-group-type="heading">
<subject>Cardiology</subject>
</subj-group></subj-group></article-categories>
<title-group>
<article-title>Does any specific infection cause Kawasaki disease?</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9542-8250</contrib-id>
<name><surname>Lee</surname><given-names>Dong Seok</given-names></name>
<degrees>MD</degrees>
<degrees>PhD</degrees>
<xref ref-type="corresp" rid="c1-kjp-2019-00129"/>
<xref ref-type="aff" rid="af1-kjp-2019-00129"></xref>
</contrib>
<aff id="af1-kjp-2019-00129">
Department of Pediatrics, Dongguk University Gyeongju Hospital, Dongguk University College of Medicine, Gyeongju, <country>Korea</country></aff>
</contrib-group>
<author-notes>
<corresp id="c1-kjp-2019-00129">Corresponding author: Dong Seok Lee, MD, PhD Department of Pediatrics, Dongguk University Gyeongju Hospital, Dongguk University College of Medicine, 87 Dongdaero, Gyeongju 38067, Korea Tel: +82-54-770-8255 Fax: +82-54-770-8378 E-mail: <email>lds117@dongguk.ac.kr</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>6</month>
<year>2019</year></pub-date>
<pub-date pub-type="epub">
<day>3</day>
<month>5</month>
<year>2019</year></pub-date>
<volume>62</volume>
<issue>6</issue>
<fpage>213</fpage>
<lpage>214</lpage>
<history>
<date date-type="received">
<day>12</day>
<month>2</month>
<year>2019</year></date>
<date date-type="rev-recd">
<day>25</day>
<month>3</month>
<year>2019</year></date>
<date date-type="accepted">
<day>3</day>
<month>5</month>
<year>2019</year></date>
</history>
<permissions>
<copyright-statement>Copyright &#x000a9; 2019 by The Korean Pediatric Society</copyright-statement>
<copyright-year>2019</copyright-year>
<license>
<license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions>
</article-meta></front>
<body>
<p>Kawasaki disease (KD) is an acute self-limited vasculitis of unknown etiology that occurs predominantly in infants and children. The etiology of this disease remains a major pediatric mystery. Nonetheless, the self-limited clinical findings and generally nonrecurring nature of this febrile illness are highly suggestive of an infection rather than an autoimmune process &#x0005b;<xref ref-type="bibr" rid="b1-kjp-2019-00129">1</xref>&#x0005d;.</p>
<p>Numerous reports confirming viral and bacterial infections associated with KD outbreaks have been reported &#x0005b;<xref ref-type="bibr" rid="b2-kjp-2019-00129">2</xref>&#x0005d;. However, multiple investigations over several decades have demonstrated that no known unique infectious agent is closely related with KD etiology &#x0005b;<xref ref-type="bibr" rid="b1-kjp-2019-00129">1</xref>,<xref ref-type="bibr" rid="b3-kjp-2019-00129">3</xref>,<xref ref-type="bibr" rid="b4-kjp-2019-00129">4</xref>&#x0005d;.</p>
<p>Taken together, many epidemiologic and clinical findings best support the hypothesis that KD is caused by a very common but unidentified infectious agent resulting in KD children with an underlying genetic predisposition.</p>
<p>Early studies of isolation of superantigen-producing bacteria or selective expansion of V&#x003b2; family T-cell receptor suggested group A <italic>Streptococcus</italic> or <italic>Staphylococcus aureus</italic> as a powerful cause of KD &#x0005b;<xref ref-type="bibr" rid="b5-kjp-2019-00129">5</xref>,<xref ref-type="bibr" rid="b6-kjp-2019-00129">6</xref>&#x0005d;. However, several subsequent papers reported no significant difference in superantigens between KD patients and controls &#x0005b;<xref ref-type="bibr" rid="b7-kjp-2019-00129">7</xref>&#x0005d;. Thus, the current understanding of the immune response favors the classic antigen that is protective against repeated exposure in most patients &#x0005b;<xref ref-type="bibr" rid="b1-kjp-2019-00129">1</xref>,<xref ref-type="bibr" rid="b3-kjp-2019-00129">3</xref>&#x0005d;.</p>
<p>The recently published article entitled &#x0201c;High antistreptolysin O (ASO) titer is associated with coronary artery lesions in patients with Kawasaki disease&#x0201d; was interesting &#x0005b;<xref ref-type="bibr" rid="b8-kjp-2019-00129">8</xref>&#x0005d;. The authors found that high ASO titers showed higher rates of a severe clinical course or coronary artery lesions (CALs). This is a very interesting results, because it has not been clearly demonstrated that a specific infection causes CALs in KD. However, there appears to be insufficient evidence to determine the acute infection of group A <italic>Streptococcus</italic>. Additionally, specific examinations such as throat culture, rapid antigen test, or other streptococcal antibody tests may be needed to determine the timing of infection. Analyses of whether patients had already known high risk factors or high ASO levels acted as risk factors are also needed since no reports to date have examined whether a high ASO increases the risk in KD patients. But detailed evaluation of group A streptococcal infection is required in future KD patients.</p>
<p>Another interesting topic is that if infectious diseases are identified, intravenous gamma globulin (IVIG) resistance or CALs may increase in KD patients.</p>
<p>According to one report, the simultaneous infection of group A Streptococcus in KD patients showed no difference in treatment response or CAL rate &#x0005b;<xref ref-type="bibr" rid="b5-kjp-2019-00129">5</xref>&#x0005d;. A single-center retrospective study was performed to determine the effect of coincident infection (including streptococcal infection) at the time of KD diagnosis on treatment response and coronary artery outcomes. As a result, a broad spectrum of infectious agents was found, but infections at the time of KD diagnosis were not statistically significantly associated with IVIG treatment response or coronary artery outcomes compared to those of patients without infections, even after the adjustment for other factors that may influence CALs &#x0005b;<xref ref-type="bibr" rid="b2-kjp-2019-00129">2</xref>&#x0005d;. Based on these results, it is believed that there are no unique infections in KD patients that respond particularly poorly to IVIG treatment or cause CALs.</p>
<p>Recent reports suggested the importance of viral infection in KD-related infectious diseases. Failure to respond to antibiotic therapy, a common susceptible age, specific seasonality, and the similar spread pattern of viral illness in patients with KD makes a viral etiology more likely than a bacterial one &#x0005b;<xref ref-type="bibr" rid="b1-kjp-2019-00129">1</xref>,<xref ref-type="bibr" rid="b3-kjp-2019-00129">3</xref>&#x0005d;.</p>
<p>Moreover, the prevalence of CD8T cells and the upregulation of cytotoxic T cells and interferon pathway genes in the coronary arteries of children who have died of KD are highly suggestive of a viral etiology &#x0005b;<xref ref-type="bibr" rid="b3-kjp-2019-00129">3</xref>&#x0005d;. The molecular analysis of the oligoclonal immunoglobulin A response in acute KD led to the production of synthetic KD antibodies that identify RNA-containing cytoplasmic inclusion bodies in acute KD ciliated bronchial epithelial tissues. Light and electron microscopic observations showed that the inclusion bodies are consistent with aggregates of viral proteins and nucleic acids &#x0005b;<xref ref-type="bibr" rid="b9-kjp-2019-00129">9</xref>&#x0005d;. These biochemical and pathological features increase the likelihood of a viral infection as the cause of KD.</p>
<p>In conclusion, although the cause of KD remains to be elucidated, it is believed that infectious diseases are the most likely. Although no solitary causative infectious agents have been discovered to date, studies should continue to determine the etiology of KD. These efforts will bring novel strategies for the treatment and prognosis of KD patients in the near future.</p>
</body>
<back>
<fn-group>
<fn fn-type="conflict"><p>No potential conflicts of interest relevant to this article was reported.</p></fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="b1-kjp-2019-00129">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Rowley</surname><given-names>AH</given-names></name>
</person-group>
<article-title>Is Kawasaki disease an infectious disorder?</article-title>
<source>Int J Rheum Dis</source>
<year>2018</year>
<volume>21</volume>
<fpage>20</fpage>
<lpage>5</lpage>
</element-citation></ref>
<ref id="b2-kjp-2019-00129">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Benseler</surname><given-names>SM</given-names></name>
<name><surname>McCrindle</surname><given-names>BW</given-names></name>
<name><surname>Silverman</surname><given-names>ED</given-names></name>
<name><surname>Tyrrell</surname><given-names>PN</given-names></name>
<name><surname>Wong</surname><given-names>J</given-names></name>
<name><surname>Yeung</surname><given-names>RS</given-names></name>
</person-group>
<article-title>Infections and Kawasaki disease: implications for coronary artery outcome</article-title>
<source>Pediatrics</source>
<year>2005</year>
<volume>116</volume>
<fpage>e760</fpage>
<lpage>6</lpage>
</element-citation></ref>
<ref id="b3-kjp-2019-00129">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Rowley</surname><given-names>AH</given-names></name>
<name><surname>Shulman</surname><given-names>ST</given-names></name>
</person-group>
<article-title>The epidemiology and pathogenesis of Kawasaki disease</article-title>
<source>Front Pediatr</source>
<year>2018</year>
<volume>6</volume>
<fpage>374</fpage>
</element-citation></ref>
<ref id="b4-kjp-2019-00129">
<label>4</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>McCrindle</surname><given-names>BW</given-names></name>
<name><surname>Rowley</surname><given-names>AH</given-names></name>
<name><surname>Newburger</surname><given-names>JW</given-names></name>
<name><surname>Burns</surname><given-names>JC</given-names></name>
<name><surname>Bolger</surname><given-names>AF</given-names></name>
<name><surname>Gewitz</surname><given-names>M</given-names></name>
<etal/>
</person-group>
<article-title>Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association</article-title>
<source>Circulation</source>
<year>2017</year>
<volume>135</volume>
<fpage>927</fpage>
<lpage>99</lpage>
</element-citation></ref>
<ref id="b5-kjp-2019-00129">
<label>5</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Cox</surname><given-names>F</given-names></name>
<name><surname>Foshee</surname><given-names>W</given-names></name>
<name><surname>Miller</surname><given-names>J</given-names><suffix>Jr</suffix></name>
<name><surname>Moore</surname><given-names>S</given-names></name>
</person-group>
<article-title>Simultaneous Kawasaki disease and group A streptococcal pharyngitis</article-title>
<source>Clin Pediatr (Phila)</source>
<year>1993</year>
<volume>32</volume>
<fpage>48</fpage>
<lpage>50</lpage>
</element-citation></ref>
<ref id="b6-kjp-2019-00129">
<label>6</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Matsubara</surname><given-names>K</given-names></name>
<name><surname>Fukaya</surname><given-names>T</given-names></name>
</person-group>
<article-title>The role of superantigens of group A Streptococcus and Staphylococcus aureus in Kawasaki disease</article-title>
<source>Curr Opinion Infect Dis</source>
<year>2007</year>
<volume>20</volume>
<fpage>298</fpage>
<lpage>303</lpage>
</element-citation></ref>
<ref id="b7-kjp-2019-00129">
<label>7</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Morita</surname><given-names>A</given-names></name>
<name><surname>Imada</surname><given-names>Y</given-names></name>
<name><surname>Igarashi</surname><given-names>H</given-names></name>
<name><surname>Yutsudo</surname><given-names>T</given-names></name>
</person-group>
<article-title>Serologic evidence that streptococcal superantigens are not involved in the pathogenesis of Kawasaki disease</article-title>
<source>Microbiol Immunol</source>
<year>1997</year>
<volume>41</volume>
<fpage>895</fpage>
<lpage>900</lpage>
</element-citation></ref>
<ref id="b8-kjp-2019-00129">
<label>8</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Min</surname><given-names>DE</given-names></name>
<name><surname>Kim</surname><given-names>DH</given-names></name>
<name><surname>Han</surname><given-names>MY</given-names></name>
<name><surname>Cha</surname><given-names>SH</given-names></name>
<name><surname>Yoon</surname><given-names>KL</given-names></name>
</person-group>
<article-title>High antistreptolysin O titer is associated with coronary artery lesions in patients with Kawasaki disease</article-title>
<source>Korean J Pediatr</source>
<year>2018</year>
<month>Nov</month>
<day>7</day>
<comment>[Epub]. <ext-link xlink:href="https://doi.org/10.3345/kjp.2018.06989" ext-link-type="uri">https://doi.org/10.3345/kjp.2018.06989</ext-link></comment>
</element-citation></ref>
<ref id="b9-kjp-2019-00129">
<label>9</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Rowley</surname><given-names>AH</given-names></name>
<name><surname>Baker</surname><given-names>SC</given-names></name>
<name><surname>Shulman</surname><given-names>ST</given-names></name>
<name><surname>Garcia</surname><given-names>FL</given-names></name>
<name><surname>Fox</surname><given-names>LM</given-names></name>
<name><surname>Kos</surname><given-names>IM</given-names></name>
<etal/>
</person-group>
<article-title>RNA-containing cytoplasmic inclusion bodies in ciliated bronchial epithelium months to years after acute Kawasaki disease</article-title>
<source>PLoS One</source>
<year>2008</year>
<volume>3</volume>
<elocation-id>e1582</elocation-id>
</element-citation></ref></ref-list>
</back></article>